© 2022 MJH Life Sciences and Urology Times. All rights reserved.
© 2022 MJH Life Sciences™ and Urology Times. All rights reserved.
August 21, 2020
Urologists and patients show resilience, but we must be better prepared in the future, says urologist R. Jonathan Henderson, MD.
August 19, 2020
Combination therapy is the first-line standard for metastatic renal cell carcinoma.
Patients with cancer are particularly susceptible to negative consequences of COVID-19.
August 18, 2020
Next-generation sequencing identifies subtypes that may benefit from immune checkpoint inhibitors.
July 07, 2020
BLC with hexaminolevulinate can be an easily replicable procedure
in patients with non–muscle-invasive bladder cancer.